JP2000290633A - Adhesive for organism tissue - Google Patents
Adhesive for organism tissueInfo
- Publication number
- JP2000290633A JP2000290633A JP11100154A JP10015499A JP2000290633A JP 2000290633 A JP2000290633 A JP 2000290633A JP 11100154 A JP11100154 A JP 11100154A JP 10015499 A JP10015499 A JP 10015499A JP 2000290633 A JP2000290633 A JP 2000290633A
- Authority
- JP
- Japan
- Prior art keywords
- adhesive
- water
- component
- gelatin
- soluble
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000853 adhesive Substances 0.000 title claims abstract description 29
- 230000001070 adhesive effect Effects 0.000 title claims abstract description 29
- 229920002101 Chitin Polymers 0.000 claims abstract description 19
- 108010010803 Gelatin Proteins 0.000 claims abstract description 17
- 150000001299 aldehydes Chemical class 0.000 claims abstract description 17
- 229920000159 gelatin Polymers 0.000 claims abstract description 17
- 239000008273 gelatin Substances 0.000 claims abstract description 17
- 235000019322 gelatine Nutrition 0.000 claims abstract description 17
- 235000011852 gelatine desserts Nutrition 0.000 claims abstract description 17
- 239000003431 cross linking reagent Substances 0.000 claims abstract description 12
- LEQAOMBKQFMDFZ-UHFFFAOYSA-N glyoxal Chemical compound O=CC=O LEQAOMBKQFMDFZ-UHFFFAOYSA-N 0.000 claims abstract description 10
- 102000008186 Collagen Human genes 0.000 claims abstract description 9
- 108010035532 Collagen Proteins 0.000 claims abstract description 9
- 229920001661 Chitosan Polymers 0.000 claims abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 8
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims abstract description 6
- 230000021736 acetylation Effects 0.000 claims abstract description 6
- 238000006640 acetylation reaction Methods 0.000 claims abstract description 6
- 229940015043 glyoxal Drugs 0.000 claims abstract description 5
- ZNZYKNKBJPZETN-WELNAUFTSA-N Dialdehyde 11678 Chemical compound N1C2=CC=CC=C2C2=C1[C@H](C[C@H](/C(=C/O)C(=O)OC)[C@@H](C=C)C=O)NCC2 ZNZYKNKBJPZETN-WELNAUFTSA-N 0.000 claims abstract description 4
- PCSMJKASWLYICJ-UHFFFAOYSA-N Succinic aldehyde Chemical compound O=CCCC=O PCSMJKASWLYICJ-UHFFFAOYSA-N 0.000 claims abstract description 4
- JGEMYUOFGVHXKV-UPHRSURJSA-N malealdehyde Chemical compound O=C\C=C/C=O JGEMYUOFGVHXKV-UPHRSURJSA-N 0.000 claims abstract description 4
- 230000001588 bifunctional effect Effects 0.000 claims description 10
- 239000003106 tissue adhesive Substances 0.000 claims description 5
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 abstract description 8
- 210000001519 tissue Anatomy 0.000 description 10
- 238000004513 sizing Methods 0.000 description 7
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 239000012153 distilled water Substances 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 239000003292 glue Substances 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 2
- 229920001651 Cyanoacrylate Polymers 0.000 description 2
- 108010080379 Fibrin Tissue Adhesive Proteins 0.000 description 2
- MWCLLHOVUTZFKS-UHFFFAOYSA-N Methyl cyanoacrylate Chemical compound COC(=O)C(=C)C#N MWCLLHOVUTZFKS-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 102100028175 Abasic site processing protein HMCES Human genes 0.000 description 1
- 239000004971 Cross linker Substances 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- AZKVWQKMDGGDSV-BCMRRPTOSA-N Genipin Chemical compound COC(=O)C1=CO[C@@H](O)[C@@H]2C(CO)=CC[C@H]12 AZKVWQKMDGGDSV-BCMRRPTOSA-N 0.000 description 1
- 101001006387 Homo sapiens Abasic site processing protein HMCES Proteins 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000006065 biodegradation reaction Methods 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 238000013130 cardiovascular surgery Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- BXKDSDJJOVIHMX-UHFFFAOYSA-N edrophonium chloride Chemical compound [Cl-].CC[N+](C)(C)C1=CC=CC(O)=C1 BXKDSDJJOVIHMX-UHFFFAOYSA-N 0.000 description 1
- AZKVWQKMDGGDSV-UHFFFAOYSA-N genipin Natural products COC(=O)C1=COC(O)C2C(CO)=CCC12 AZKVWQKMDGGDSV-UHFFFAOYSA-N 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000005022 packaging material Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 229940075469 tissue adhesives Drugs 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
- Adhesives Or Adhesive Processes (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は生体組織用接着剤に
関するものである。より詳細には、コラーゲン蛋白部分
加水分解物質を主成分とする糊成分及び2官能性乃至多
官能性アルデヒド類を主成分とする架橋剤とからなる止
血性能及び接着性能に優れ、生体吸収性で且つ優れた安
全性を有する生体組織用接着剤に関するものである。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a living tissue adhesive. More specifically, it is excellent in hemostatic performance and adhesive performance comprising a glue component mainly composed of a collagen protein partial hydrolyzate as a main component and a crosslinking agent mainly composed of bifunctional or polyfunctional aldehydes. The present invention also relates to a biological tissue adhesive having excellent safety.
【0002】[0002]
【従来の技術】生体組織用接着剤として従来から種々の
接着剤が提案され、この内シアノアクリレート系、フィ
ブリン糊並びにゼラチンーレゾルシンー2官能性アルデ
ヒド系が実際の臨床の場で用いられている。2. Description of the Related Art Conventionally, various adhesives have been proposed as adhesives for living tissues, of which cyanoacrylate, fibrin glue and gelatin-resorcin-bifunctional aldehyde are used in actual clinical practice. .
【0003】[0003]
【発明が解決しようとする課題】従来から臨床の場で用
いられている組織用接着剤の特徴を挙げると、先ずシア
ノアクリレート系は接着速度と接着強度は良好である
が、接着面に柔軟性が失われていることと生体内での分
解により安全性に好ましくない物質が生成される恐れの
あることが大きな問題点とされてる。フィブリン糊に関
しては、生体由来の物質である為、生体内分解による生
成物は安全性の点で問題がないと考えられるが、接着強
度が乏しいこと、更に生体由来物質によるウイルス感染
の危険性も無視できないことなどの問題点がある。また
ゼラチンーレゾルシンー2官能性アルデヒド系において
は、接着強度については満足されるものであるが、架橋
剤のアルデヒド類として毒性の高いホルムアルデヒドが
用いられていること並びに未反応物が生体組織に悪影響
を及ぼす恐れのあるレゾルシンを用いていることにより
緊急を要する治療にのみその使用が限られている。よっ
て、接着強度が良好で且つ安全性のより高い生体組織用
接着剤の開発が多くの臨床の場で待ち望まれている。The characteristics of tissue adhesives conventionally used in clinical settings are as follows. First, cyanoacrylate-based adhesives have good adhesive speed and adhesive strength, but have a soft adhesive surface. It has been a serious problem that the compound has been lost and there is a risk that a substance that is not preferable for safety may be generated by decomposition in a living body. As for fibrin glue, it is considered that there is no problem in terms of safety because the product is derived from the living body, so the product due to biodegradation is poor, but the adhesive strength is poor and the risk of virus infection by the biological material is also high. There are problems that cannot be ignored. In the case of gelatin-resorcin-bifunctional aldehydes, the adhesive strength is satisfactory, but highly toxic formaldehyde is used as a cross-linking aldehyde, and unreacted substances adversely affect biological tissues. The use of resorcinol, which can cause illness, is limited to only those treatments that require urgency. Therefore, development of an adhesive for living tissue having good adhesive strength and higher safety has been awaited in many clinical settings.
【0004】[0004]
【課題を解決するための手段】本発明は以下のものであ
る。 コラーゲン蛋白部分加水分解物質及び水溶性キチン
誘導体を主成分とする糊剤と2官能性乃至多官能性アル
デヒドを主成分とする架橋剤とからなる生体組織用接着
剤。 前記コラーゲン蛋白部分加水分解物質が80℃以下
の温水に可溶なゼラチンである上記記載の生体組織用
接着剤。 前記水溶性キチン誘導体がアセチル化率が約45%
乃至約55%の範囲にあるキトサン又はカルボキシメチ
ルキチンである上記又は記載の生体組織用接着剤。 前記2官能性乃至多官能性アルデヒドがグリオキサ
ール、スクシンアルデヒド、グルタールアルデヒド、マ
レアルデヒドからなる群から選ばれたジアルデヒドであ
る上記乃至のいずれかに記載の生体組織用接着剤。 コラーゲン蛋白部分加水分解物質及び水溶性キチン
誘導体を主成分として充填した第1の容器と2官能性乃
至多官能性アルデヒドを主成分として充填した第2の容
器とからなる生体組織用接着剤キット。The present invention is as follows. An adhesive for living tissue comprising a glue mainly composed of a collagen protein partial hydrolyzate and a water-soluble chitin derivative and a crosslinking agent mainly containing a bifunctional or polyfunctional aldehyde. The adhesive for living tissue as described above, wherein the collagen protein partial hydrolyzate is gelatin soluble in warm water of 80 ° C. or lower. The water-soluble chitin derivative has an acetylation rate of about 45%
Or a chitosan or carboxymethyl chitin in the range of from about 55% to about 55%. The biological tissue adhesive according to any one of the above items, wherein the bifunctional to polyfunctional aldehyde is a dialdehyde selected from the group consisting of glyoxal, succinaldehyde, glutaraldehyde, and malealdehyde. An adhesive kit for living tissue, comprising a first container filled with a collagen protein partial hydrolyzate and a water-soluble chitin derivative as main components, and a second container filled with a bifunctional or polyfunctional aldehyde as a main component.
【0005】本発明によれば、糊剤成分としてゼラチン
に水溶性キチン誘導体を加えることにより、ゼラチン単
独では得られなかった接着強度が実現され、しかもゼラ
チンの使用量も大幅に減じられることにより少ない糊剤
量で高い接着性が得られる。このことにより生体に対す
る異物の量を低減でき、創部の回復が良好となるものと
期待される。また、架橋剤の2官能性乃至多官能性アル
デヒド類としては、毒性の高いホルムアルデヒドの使用
を避け、従来から心臓血管外科領域などで用いられてい
るグルタールアルデヒドやグリオキサール等を主として
使用する。According to the present invention, by adding a water-soluble chitin derivative to gelatin as a sizing agent component, an adhesive strength which cannot be obtained with gelatin alone is realized, and the amount of gelatin used is greatly reduced, thereby reducing the amount of gelatin used. High adhesiveness can be obtained with the amount of paste. As a result, it is expected that the amount of foreign matter to the living body can be reduced, and that the recovery of the wound can be improved. In addition, as a bifunctional or polyfunctional aldehyde as a crosslinking agent, glutaraldehyde, glyoxal, or the like conventionally used in the field of cardiovascular surgery and the like is mainly used, avoiding use of highly toxic formaldehyde.
【0006】本発明の糊剤の主成分の一つであるコラー
ゲン蛋白部分加水分解物質としてはゼラチンが好適に用
いられ、それは公知の製造法により製造されるのもので
あり、通常重量平均分子量が10,000乃至70,0
00程度で、且つ少なくとも温水に可溶なものである。
更に、原料の由来が明確であること、即ち狂牛病病原体
に汚染されていないものであることが必須である。[0006] Gelatin is preferably used as a partial hydrolyzate of collagen protein, which is one of the main components of the sizing agent of the present invention, which is produced by a known production method and usually has a weight-average molecular weight. 10,000 to 70,0
It is about 00 and at least soluble in warm water.
Furthermore, it is essential that the source of the raw material is clear, that is, it is not contaminated by the mad cow disease pathogen.
【0007】本発明の糊剤のもう一方の主成分である水
溶性キチン誘導体としては、公知の方法で部分脱アセチ
ル化されたキチンもしくは部分アセチル化されたキトサ
ンで、そのアセチル化率が約45%乃至約55%のもの
が好ましい。また、部分脱アセチル化カルボキシメチル
キチンも好適に使用される。The water-soluble chitin derivative which is the other main component of the sizing agent of the present invention is chitin partially deacetylated or chitosan partially acetylated by a known method and has an acetylation rate of about 45%. % To about 55%. Partially deacetylated carboxymethyl chitin is also preferably used.
【0008】本発明で用いられる架橋剤成分としては、
2官能性乃至多官能性アルデヒド類、即ちグリオキサー
ル、スクシンアルデヒド、グルタールアルデヒド、及び
マレアルデヒドからなる群から選ばれたジアルデヒド、
更に天然物由来の多官能性アルデヒド、例えばデキスト
ランジアルデヒド、m-periodate により酸化された糖
類、 Genipin なども毒性の低い架橋剤として用いること
ができる。The crosslinking agent component used in the present invention includes:
Di- or polyfunctional aldehydes, i.e., dialdehydes selected from the group consisting of glyoxal, succinaldehyde, glutaraldehyde, and malealdehyde;
Furthermore, polyfunctional aldehydes derived from natural products, such as dextran dialdehyde, saccharides oxidized with m-periodate, and Genipin, can also be used as low-toxicity crosslinking agents.
【0009】本発明では糊剤の主成分としてゼラチン及
び水溶性キチン誘導体を用いるが、その水溶液中での濃
度は、ゼラチンが好ましくは約5〜50重量%、更に好
ましくは10〜30重量%、水溶性キチン誘導体が好ま
しくは約0.1〜約10重量%、更に好ましくは約0.
3〜約5重量%の範囲である。In the present invention, gelatin and a water-soluble chitin derivative are used as main components of the sizing agent. The concentration of gelatin in an aqueous solution is preferably about 5 to 50% by weight, more preferably 10 to 30% by weight. Preferably, the water-soluble chitin derivative is about 0.1 to about 10% by weight, more preferably about 0.1% by weight.
It ranges from 3 to about 5% by weight.
【0010】また、本発明における2官能性乃至多官能
性アルデヒドは、好ましくは約1〜約20重量%の範囲
の水溶液で使用される。The bifunctional to polyfunctional aldehyde of the present invention is preferably used in an aqueous solution in the range of about 1 to about 20% by weight.
【0011】本発明の生体組織用接着剤は、ゼラチン及
び水溶性キチン誘導体を主成分とする糊剤水溶液を無菌
下に調製し無菌下に容器に充填するか、予め容器に糊剤
水溶液を充填した後それを滅菌処理することにより糊剤
を調製し、1種もしくは2種以上の2官能性乃至多官能
性アルデヒドの水溶液を無菌下に調製し、無菌下に容器
に充填するか、予め容器にアルデヒドの水溶液を充填し
た後それを滅菌処理することにより架橋剤を調製する。The adhesive for living tissue of the present invention is prepared by aseptically preparing an aqueous paste solution containing gelatin and a water-soluble chitin derivative as main components and filling the container under aseptic conditions, or filling the container with the paste aqueous solution in advance. After that, it is sterilized to prepare a paste, and an aqueous solution of one or two or more bifunctional or polyfunctional aldehydes is prepared under aseptic conditions, and filled in a container under aseptic conditions, or A cross-linking agent is prepared by filling an aqueous solution of an aldehyde into the mixture and then sterilizing it.
【0012】実際の生体組織の接着に際しては、公知の
接着剤と同様に生体組織に糊剤を塗布した後、架橋剤を
加え、接着部を押圧し硬化させる。架橋剤の濃度並びに
糊剤に対する添加量に関しては、使用される糊剤の組成
や濃度により異なるが、十分な硬化が約1分乃至約5分
程度で達成されるよう調整されることが望ましい。In actual bonding of a living tissue, a glue is applied to the living tissue in the same manner as a known adhesive, a crosslinking agent is added, and the bonded portion is pressed and cured. The concentration of the cross-linking agent and the amount added to the sizing agent vary depending on the composition and concentration of the sizing agent to be used, but it is desirable that the curing is adjusted so that sufficient curing is achieved in about 1 to about 5 minutes.
【0013】本発明において、糊剤及び架橋剤はバイア
ル瓶もしくは注射筒に充填され、必要に応じて脱酸素剤
等を同封し、酸素を透過せしめない包装材で包装され
る。In the present invention, the sizing agent and the cross-linking agent are filled in a vial or a syringe, and if necessary, are enclosed with a deoxidizer and the like, and are packaged in a packaging material that does not allow oxygen to pass therethrough.
【0014】[0014]
【実施例】以下実施例に基づき本発明を更に詳細に説明
する。The present invention will be described in more detail with reference to the following examples.
【0015】〔実施例1〕食品用ゼラチン20重量部及び
アセチル化率50%のキトサン(商品名:コーヨーキトサ
ン DAC-50)0.5 重量部を注射用蒸留水79.5重量部に溶
解し糊剤溶液を調製した(糊剤Aとする)。別途、グル
タールアルデヒドをそれぞれ10重量%、5 重量%、及び
2.5 重量%含む水溶液を調製し架橋剤溶液を得た。Example 1 20 parts by weight of gelatin for food and 0.5 parts by weight of chitosan (trade name: Koyo Chitosan DAC-50) having an acetylation ratio of 50% were dissolved in 79.5 parts by weight of distilled water for injection to prepare a paste solution. Prepared (Glue A). Separately, glutaraldehyde is 10% by weight, 5% by weight, and
An aqueous solution containing 2.5% by weight was prepared to obtain a crosslinking agent solution.
【0016】〔実施例2〕食品用ゼラチン30重量%及び
アセチル化率50%のキトサン(商品名:コーヨーキトサ
ンDAC-50)1重量部を注射用蒸留水69重量部に溶解し糊
剤溶液を調製した(糊剤Bとする)。Example 2 1 part by weight of chitosan (trade name: Koyo Chitosan DAC-50) having 30% by weight of gelatin for food and 50% of acetylation ratio was dissolved in 69 parts by weight of distilled water for injection to prepare a paste solution. Prepared (Glue B).
【0017】〔実施例3〕食品用ゼラチン25重量部及び
部分脱アセチル化カルボキシメチルキチン(商品名:コ
ーヨーCMキチン)5重量部を注射用蒸留水70重量部に
溶解し糊剤溶液を調製した(糊剤Cとする)。Example 3 25 parts by weight of gelatin for food and 5 parts by weight of partially deacetylated carboxymethyl chitin (trade name: Koyo CM chitin) were dissolved in 70 parts by weight of distilled water for injection to prepare a paste solution. (Glue C).
【0018】〔比較例1〕食品用ゼラチン40重量部を注
射用蒸留水60重量部に溶解しゼラチン単独の糊剤溶液を
調製した(糊剤Dとする)。Comparative Example 1 40 parts by weight of gelatin for food was dissolved in 60 parts by weight of distilled water for injection to prepare a paste solution of gelatin alone (referred to as paste D).
【0019】〔接着強度試験〕市販の牛心膜パッチ(商
品名:ティッシュガード)を幅1cm×長さ5cmに切り接
着強度試験用材料とした。試験片表面の水分をろ紙にて
出来る限り除去し実施例1〜3で調製した糊剤を片方端
1cm に0.1g塗布した後、そこへ実施例1で調製した所
定濃度の架橋剤10μlを添加し、直ちに別の接着片を接
着面が1cm となるように貼り合わせ、接着面に100gの
分銅を置き2分間押圧後分銅を除き、引き続き3分間放
置後引張り試験(試験機:TOYO BALDWIN製TENSILON RTM
100 、引張り速度:3cm/min)を行った。結果を表1に
示す。[Adhesion strength test] A commercially available bovine pericardium patch (trade name: tissue guard) was cut into a width of 1 cm and a length of 5 cm to obtain a material for an adhesion strength test. Moisture on the surface of the test piece was removed as much as possible with a filter paper, and 0.1 g of the paste prepared in Examples 1 to 3 was applied to 1 cm 2 at one end, and then 10 μl of the crosslinker of a predetermined concentration prepared in Example 1 was added thereto. Immediately, attach another piece of adhesive so that the adhesive surface is 1 cm, put a weight of 100 g on the adhesive surface, press for 2 minutes, remove the weight, then leave it for 3 minutes, and then pull it out (test machine: TENSILON made by TOYO BALDWIN) RTM
100 at a pulling speed of 3 cm / min). Table 1 shows the results.
【0020】[0020]
【表1】 [Table 1]
フロントページの続き Fターム(参考) 4C081 AC04 BA11 BB04 CC05 CD091 CD121 CD151 CE08 DA15 DC12 4J040 BA141 BA142 BA161 BA162 HB17 JA02 JA13 JB11 KA16 LA06 LA11 MA14 NA02 Continued on the front page F term (reference) 4C081 AC04 BA11 BB04 CC05 CD091 CD121 CD151 CE08 DA15 DC12 4J040 BA141 BA142 BA161 BA162 HB17 JA02 JA13 JB11 KA16 LA06 LA11 MA14 NA02
Claims (5)
溶性キチン誘導体を主成分とする糊剤と2官能性乃至多
官能性アルデヒドを主成分とする架橋剤とからなる生体
組織用接着剤。1. An adhesive for living tissue comprising a paste mainly composed of a collagen protein partially hydrolyzed substance and a water-soluble chitin derivative and a crosslinking agent mainly composed of a bifunctional or polyfunctional aldehyde.
80℃以下の温水に可溶なゼラチンである請求項1記載
の生体組織用接着剤。2. The adhesive for living tissue according to claim 1, wherein the collagen protein partial hydrolyzate is gelatin soluble in hot water at 80 ° C. or lower.
が約45%乃至約55%の範囲にあるキトサン又はカル
ボキシメチルキチンである請求項1又は2記載の生体組
織用接着剤。3. The adhesive for living tissue according to claim 1, wherein the water-soluble chitin derivative is chitosan or carboxymethyl chitin having an acetylation ratio in a range of about 45% to about 55%.
グリオキサール、スクシンアルデヒド、グルタールアル
デヒド、マレアルデヒドからなる群から選ばれたジアル
デヒドである請求項1乃至3のいずれかに記載の生体組
織用接着剤。4. The living body according to claim 1, wherein the bifunctional to polyfunctional aldehyde is a dialdehyde selected from the group consisting of glyoxal, succinaldehyde, glutaraldehyde, and malealdehyde. Tissue adhesive.
溶性キチン誘導体を主成分として充填した第1の容器と
2官能性乃至多官能性アルデヒドを主成分として充填し
た第2の容器とからなる生体組織用接着剤キット。5. A biological tissue comprising a first container filled with a collagen protein partial hydrolyzate and a water-soluble chitin derivative as main components, and a second container filled with a bifunctional or polyfunctional aldehyde as a main component. Adhesive kit.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11100154A JP2000290633A (en) | 1999-04-07 | 1999-04-07 | Adhesive for organism tissue |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11100154A JP2000290633A (en) | 1999-04-07 | 1999-04-07 | Adhesive for organism tissue |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2000290633A true JP2000290633A (en) | 2000-10-17 |
Family
ID=14266416
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP11100154A Withdrawn JP2000290633A (en) | 1999-04-07 | 1999-04-07 | Adhesive for organism tissue |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2000290633A (en) |
Cited By (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003085059A1 (en) * | 2002-04-04 | 2003-10-16 | S E. Chemical Kabushiki Kaisha | Adhesive composition for processed wood product, and processed wood product produced by use of said adhesive composition |
| WO2004071544A1 (en) | 2003-02-13 | 2004-08-26 | National Institute For Materials Science | Biodegradable and pressure-sensitive material for medical use |
| JP2005021454A (en) * | 2003-07-03 | 2005-01-27 | Hiroshi Nishida | Tissue adhesive with polymeric micelle as effective component |
| CN1327909C (en) * | 2004-02-06 | 2007-07-25 | 上海组织工程研究与开发中心 | Water soluble binder and its application |
| JP2008301955A (en) * | 2007-06-06 | 2008-12-18 | Olympus Corp | Biomedical tissue joining apparatus |
| JP2010168571A (en) * | 2008-12-26 | 2010-08-05 | Ryoji Baba | Spreading material and method for manufacturing the same |
| US8460288B2 (en) | 2009-10-28 | 2013-06-11 | Olympus Corporation | Biological-tissue joining apparatus |
| WO2013053749A3 (en) * | 2011-10-11 | 2013-11-14 | Baxter International Inc. | Hemostatic compositions |
| CN103725252A (en) * | 2014-01-08 | 2014-04-16 | 四川省纺织科学研究院 | Formaldehyde-free adhesive as well as preparation method and application thereof |
| WO2017027253A1 (en) * | 2015-08-07 | 2017-02-16 | Victor Matthew Phillips | Flowable hemostatic gel composition and its methods of use |
| US10322170B2 (en) | 2011-10-11 | 2019-06-18 | Baxter International Inc. | Hemostatic compositions |
| JP2019151728A (en) * | 2018-03-02 | 2019-09-12 | 東洋紡株式会社 | Polycarboxylic acid derivative |
| US10660945B2 (en) | 2015-08-07 | 2020-05-26 | Victor Matthew Phillips | Flowable hemostatic gel composition and its methods of use |
| CN112075547A (en) * | 2020-06-04 | 2020-12-15 | 天津农学院 | Bait for cold-formed aquatic seedling as well as preparation method and application of bait |
| KR20220084885A (en) * | 2020-12-14 | 2022-06-21 | 주식회사 넥스트바이오메디컬 | Adhesive composition for in-body absorbable reinforcement materials comprising chitosan and gelatin and manufacturing method thereof |
| CN119875580A (en) * | 2025-03-26 | 2025-04-25 | 佛山市奥川顺新材料实业有限公司 | Flame-retardant glue for water-based back-spraying lamp sheet and preparation method thereof |
-
1999
- 1999-04-07 JP JP11100154A patent/JP2000290633A/en not_active Withdrawn
Cited By (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003085059A1 (en) * | 2002-04-04 | 2003-10-16 | S E. Chemical Kabushiki Kaisha | Adhesive composition for processed wood product, and processed wood product produced by use of said adhesive composition |
| WO2004071544A1 (en) | 2003-02-13 | 2004-08-26 | National Institute For Materials Science | Biodegradable and pressure-sensitive material for medical use |
| EP1598085A4 (en) * | 2003-02-13 | 2006-04-12 | Nat Inst For Materials Science | BIODEGRADABLE, PRESSURE SENSITIVE MATERIAL FOR MEDICAL USE |
| JP2005021454A (en) * | 2003-07-03 | 2005-01-27 | Hiroshi Nishida | Tissue adhesive with polymeric micelle as effective component |
| CN1327909C (en) * | 2004-02-06 | 2007-07-25 | 上海组织工程研究与开发中心 | Water soluble binder and its application |
| JP2008301955A (en) * | 2007-06-06 | 2008-12-18 | Olympus Corp | Biomedical tissue joining apparatus |
| JP2010168571A (en) * | 2008-12-26 | 2010-08-05 | Ryoji Baba | Spreading material and method for manufacturing the same |
| US8460288B2 (en) | 2009-10-28 | 2013-06-11 | Olympus Corporation | Biological-tissue joining apparatus |
| WO2013053749A3 (en) * | 2011-10-11 | 2013-11-14 | Baxter International Inc. | Hemostatic compositions |
| US10322170B2 (en) | 2011-10-11 | 2019-06-18 | Baxter International Inc. | Hemostatic compositions |
| CN103725252B (en) * | 2014-01-08 | 2016-04-20 | 四川省纺织科学研究院 | A kind of Formaldehyde-free adhesive and its preparation method and application |
| CN103725252A (en) * | 2014-01-08 | 2014-04-16 | 四川省纺织科学研究院 | Formaldehyde-free adhesive as well as preparation method and application thereof |
| WO2017027253A1 (en) * | 2015-08-07 | 2017-02-16 | Victor Matthew Phillips | Flowable hemostatic gel composition and its methods of use |
| US10660945B2 (en) | 2015-08-07 | 2020-05-26 | Victor Matthew Phillips | Flowable hemostatic gel composition and its methods of use |
| US10751444B2 (en) | 2015-08-07 | 2020-08-25 | Victor Matthew Phillips | Flowable hemostatic gel composition and its methods of use |
| JP2019151728A (en) * | 2018-03-02 | 2019-09-12 | 東洋紡株式会社 | Polycarboxylic acid derivative |
| JP7155544B2 (en) | 2018-03-02 | 2022-10-19 | 東洋紡株式会社 | Polycarboxylic acid derivative |
| CN112075547A (en) * | 2020-06-04 | 2020-12-15 | 天津农学院 | Bait for cold-formed aquatic seedling as well as preparation method and application of bait |
| KR20220084885A (en) * | 2020-12-14 | 2022-06-21 | 주식회사 넥스트바이오메디컬 | Adhesive composition for in-body absorbable reinforcement materials comprising chitosan and gelatin and manufacturing method thereof |
| KR102615766B1 (en) | 2020-12-14 | 2023-12-20 | 주식회사 넥스트바이오메디컬 | Adhesive composition for in-body absorbable reinforcement materials comprising chitosan and gelatin and manufacturing method thereof |
| CN119875580A (en) * | 2025-03-26 | 2025-04-25 | 佛山市奥川顺新材料实业有限公司 | Flame-retardant glue for water-based back-spraying lamp sheet and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2000288079A (en) | Adhesive for biotissue | |
| JP2000290633A (en) | Adhesive for organism tissue | |
| CN101209354B (en) | Medical blood-stopping healing agent for wound-surface and uses thereof | |
| CN105477678A (en) | Novel bio-medical adhesive and preparation method thereof | |
| JP5660781B2 (en) | β-1,3-glucan-derived polyaldehyde / polyamine hydrogel | |
| EP0650512B1 (en) | Aldehyde-cured proteinaceous adhesive | |
| JP3238711B2 (en) | Macromolecular polyaldehyde-based adhesive composition and method of crosslinking collagen | |
| CN105770981A (en) | Biological medical oxidative sodium carboxymethylcellulose-dopamine adhesive and preparation method thereof | |
| KR102112539B1 (en) | 2 liquid type hemostat compositions and manufacturing methods for the same | |
| US20050002893A1 (en) | Composition consisting of a polymer containing amino groups and an aldehyde containing at least three aldehyde groups | |
| JP2002526207A (en) | Double composite collagenous material, its acquisition method and therapeutic application | |
| US4621631A (en) | Process for the production of a bonded collagen fiber sheet | |
| CN107496974A (en) | A kind of two-component adhesive of medical based on glucan and chitosan and preparation method thereof | |
| WO2018079538A1 (en) | Hemostatic material | |
| CN102416194A (en) | Novel chitosan hemostatic sponge and preparation method thereof | |
| CN110935058A (en) | Double-component medical glue for rapid hemostasis and preparation method thereof | |
| CN110478523A (en) | A kind of enhanced biological adhesive of composite chitin whisker and preparation method thereof | |
| JP4585743B2 (en) | Biodegradable absorbable adhesive medical material | |
| DK2219555T3 (en) | Biocompatible phase invertible proteinaceous compositions | |
| JPH0794576B2 (en) | Flexible biodegradable film or sheet, and method for producing the same | |
| CN104258454A (en) | Medical multi-functional hemostasis material and preparation method thereof | |
| JP2594496B2 (en) | Method for producing regenerated cellulose film adhered to chitosan | |
| JP3092995B2 (en) | Chitosan composite porous body and method for preparing the same | |
| US8137450B2 (en) | Collagen-based lyophilised glue and the use thereof for producing an adhesive prosthesis | |
| CN107033258A (en) | A kind of hydroxyl butyl chitosan medical sponge and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20060406 |
|
| A761 | Written withdrawal of application |
Free format text: JAPANESE INTERMEDIATE CODE: A761 Effective date: 20080707 |